Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Short term prophylaxis against heterotopic bone after cementless hip replacement

C Wurnig1, V Auersperg, N Boehler

  • 1Department of Orthopaedics, University of Vienna, Wahringer Gurtel, Austria.

Clinical Orthopaedics and Related Research
|January 1, 1997
PubMed
Summary

Seven days of indomethacin effectively prevents severe heterotopic ossification after hip replacement, matching 14-day regimens. This offers a shorter, comparable treatment for preventing bone growth after cementless total hip arthroplasty.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping Human Fetal Brain Maturation In Vivo Using Quantitative MRI.

AJNR. American journal of neuroradiology·2021
Same author

Extendible Prostheses for Children After Resection of Primary Malignant Bone Tumor: Twenty-seven Years of Experience.

The Journal of bone and joint surgery. American volume·2015
Same author

Ethical standards for orthopaedic surgeons.

The bone & joint journal·2014
Same author

Strategies for the evaluation and selection of potential vaginal probiotics from human sources: an exemplary study.

Beneficial microbes·2014
Same author

Pt nanoparticles supported on Sb-doped SnO₂ porous structures: developments and issues.

Physical chemistry chemical physics : PCCP·2014
Same author

The pattern of the development of resistance and dependence to carbomycin in Micrococcus pyogenes var. aureus.

Antibiotics & chemotherapy (Northfield, Ill.)·2014

Area of Science:

  • Orthopedic Surgery
  • Pharmacology

Background:

  • Heterotopic ossification (HO) is a common complication after cementless total hip arthroplasty.
  • Nonsteroidal anti-inflammatory drugs, such as indomethacin, are frequently used to prevent HO.

Purpose of the Study:

  • To determine if a 7-day indomethacin regimen is as effective as a 14-day regimen in preventing HO after cementless total hip arthroplasty.

Main Methods:

  • A randomized controlled trial comparing 7-day and 14-day indomethacin treatment post-surgery.
  • Patients (n=201) received either 100 mg of indomethacin daily for 7 or 14 days.
  • HO incidence and severity were assessed at 1-year follow-up using Brooker classification.

Main Results:

  • No significant difference in HO incidence or severity between the 7-day and 14-day indomethacin groups.

Related Experiment Videos

  • Average Harris Hip Scores were comparable (91 vs. 89).
  • Adverse events (headache, dizziness, gastritis) were similar and mild in both groups.

    • Conclusions:

    • A 7-day indomethacin treatment is sufficient for preventing severe heterotopic ossification after cementless total hip arthroplasty.
    • Shorter indomethacin duration offers comparable efficacy with potentially reduced side effects.